You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inducible Caspase

Showing 1 - 25 of 277
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Lymphoma, B-Cell, Immune System Diseases Trial in Chapel Hill (iC9-CAR19 T cells, Bendamustine, Fludarabine)

Recruiting
  • Lymphoma
  • +4 more
  • iC9-CAR19 T cells
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2022

Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

Recruiting
  • Acute Lymphoblastic Leukemia
  • +2 more
  • iC9-CAR19 cells
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 21, 2022

Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

No longer available
  • Acute Lymphoblastic Leukemia
  • +2 more
  • iC9-CAR19 cells
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2021

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Brain Tumor, Pediatric, Medulloblastoma, Childhood, Embryonal Tumor Trial (GD2-CART01 (iC9-GD2-CAR T-cells))

Not yet recruiting
  • Brain Tumor, Pediatric
  • +6 more
  • GD2-CART01 (iC9-GD2-CAR T-cells)
  • (no location specified)
Mar 18, 2022

Autoimmune Diseases Trial in Shenzhen, Guilin (4SCAR T cells)

Recruiting
  • Autoimmune Diseases
  • 4SCAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Jul 17, 2022

Neuroblastoma, Neuroblastoma Recurrent, GD2-positive Solid Tumors Trial in Roma (GD2-CART01)

Recruiting
  • Neuroblastoma
  • +5 more
  • GD2-CART01
  • Roma, Italy
    Ospedale Pediatrico Bambino Gesù
Mar 9, 2022

CD19-ALL, CD19-LNH Trial in Roma (CD19-CAR T cell)

Active, not recruiting
  • CD19-ALL
  • CD19-LNH
  • CD19-CAR T cell
  • Roma, Italy
    Ospedale Pediatrico Bambino Gesù
Mar 9, 2022

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +3 more
  • BPX-501 dose 1
  • +5 more
  • Atlanta, Georgia
  • +7 more
Jul 10, 2022

Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)

Completed
  • Sarcoma
  • +3 more
  • Anti-GD2-CAR engineered T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Advanced Breast Cancer Trial in Changsha (TQB3909 tablets)

Recruiting
  • Advanced Breast Cancer
  • TQB3909 tablets
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Mar 16, 2023

Non-Alcoholic Fatty Liver Disease (NAFLD) Trial in Jakarta Pusat (Proliverenol, Placebo caplets of Proliverenol)

Recruiting
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Jakarta Pusat, Jakarta, Indonesia
    Division of Hepatology, Dr. Cipto Mangunkusumo Hospital
Nov 7, 2023

Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Neuroblastoma
  • Osteosarcoma
  • iC9.GD2.CAR.IL-15 T-cells
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jan 4, 2023

Chronic Inducible Urticaria Trial in Canada, United States (Oral EP262)

Recruiting
  • Chronic Inducible Urticaria
  • Oral EP262
  • Tampa, Florida
  • +5 more
Sep 18, 2023

Cold Urticaria Trial in Worldwide (Dupilumab SAR231893, Placebo, Non sedating H1-antihistamine)

Active, not recruiting
  • Cold Urticaria
  • Dupilumab SAR231893
  • +2 more
  • San Diego, California
  • +34 more
Nov 15, 2022

Periodontal Inflammation Trial in Cairo (diode laser, non surgical scaling)

Recruiting
  • Periodontal Inflammation
  • diode laser
  • non surgical scaling
  • Cairo, Nasrcity Nasr Street, Egypt
  • +1 more
Nov 20, 2023

Head Neck Cancer, Oral Cavity Squamous Cell Carcinoma Trial in Bern (Metformin)

Completed
  • Head and Neck Cancer
  • Oral Cavity Squamous Cell Carcinoma
  • Bern, Switzerland
    Inselspital, Bern University Hospital
Nov 17, 2021

IFN? and Inflammatory Mediators in Hemophagocytic

Completed
  • Hemophagocytic Lymphohistiocytoses
  • Blood Draws Data Collection
  • Boston, Massachusetts
    Brigham and Women's Hospital
Sep 14, 2023

Covid19 Trial in Brooklyn (Emricasan, Placebo)

Terminated
  • Covid19
  • Brooklyn, New York
    SUNY Downstate Health Sciences University
Dec 14, 2021

Chronic Inducible Urticaria Trial in Worldwide (Ligelizumab, Placebo)

Terminated
  • Chronic Inducible Urticaria
  • Litchfield Park, Arizona
  • +64 more
Jan 26, 2023

Ischemia, Coronary Artery Disease Trial in Aarhus, Turku, Uppsala (IMB-1018972, Placebo)

Recruiting
  • Ischemia
  • Coronary Artery Disease
  • Aarhus, Denmark
  • +2 more
Nov 1, 2022

Advanced Malignant Tumor Trial in Nanjing, Tianjin (TQB3909 Tablets)

Recruiting
  • Advanced Malignant Tumor
  • TQB3909 Tablets
  • Nanjing, Jiangsu, China
  • +1 more
Mar 3, 2022

Chronic Inducible Urticaria Trial in United States (barzolvolimab, Matching Placebo)

Recruiting
  • Chronic Inducible Urticaria
  • barzolvolimab
  • Matching Placebo
  • Birmingham, Alabama
  • +31 more
Jan 20, 2023

ful in Assessment for ILO? A Protocol forTwo-stage Exploratory

Recruiting
  • Vocal Cord Dysfunction
  • +3 more
  • Trans-cutaneous Laryngeal ultrasound (TLUS)
  • TLUS and simultaneous laryngoscopy
  • Preston, Lancashire, United Kingdom
    Lancashire Teaching Hospitals NHS Trust
Jan 13, 2023

Myeloma-Multiple, Myeloma, Plasma-Cell Trial run by the NCI (Cyclophosphamide, Fludarabine, Rimiducid)

Completed
Has Results
  • Myeloma-Multiple
  • Myeloma, Plasma-Cell
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 19, 2021